Results 271 to 280 of about 210,482 (340)

Clinical perspectives and comparisons between immunoglobulin G4‐related disease and antineutrophil cytoplasmic antibody‐associated vasculitis

open access: yesRheumatology &Autoimmunity, EarlyView.
Clinical perspectives and comparisons between immunoglobulin G4‐related disease and antineutrophil cytoplasmic antibody‐associated vasculitis. Abstract Both immunoglobulin (Ig) G4‐related disease (IgG4‐RD) and antineutrophil cytoplasmic antibody (ANCA)‐associated vasculitis (AAV) are systemic disorders that affect a wide range of organs.
Wenhuan Zeng, Mingxin Bai, Yanying Liu
wiley   +1 more source

Challenges in diagnosing and treating distal common bile duct adenocarcinoma: A case report with literature insights. [PDF]

open access: yesInt J Emerg Med
Alshwayyat S   +9 more
europepmc   +1 more source

Interparticle Crosslinked Ion‐Responsive Microgels for 3D and 4D (Bio)Printing Applications

open access: yesSmall, EarlyView.
A novel strategy is developed that enables interparticle crosslinking of microgels, eliminating the need for filler hydrogels and preserving essential microscale void spaces to support cell migration and vascularization. These microgels possesses unique, ion‐responsive shrinking behavior primarily by the Hofmeister effect, reversible upon the removal ...
Vaibhav Pal   +8 more
wiley   +1 more source

Surface‐Engineering of Pancreatic Islets with Chitosan Microparticles to Inhibit IBMIR in Islet Xenotransplantation

open access: yesSmall, EarlyView.
A novel surface engineering approach using chitosan microparticles (CSMP) is developed to enable stable islet conjugation and high‐capacity heparin (HEP) loading. The resulting HEP/CSMP‐islets maintain viability and function and significantly suppress IBMIR after intraportal transplantation in diabetic mice. This strategy offers a simple, biocompatible
Manju Shrestha   +11 more
wiley   +1 more source

Targeted Nanocomplex Delivery for Protecting Vascular Integrity and Enhancing Anticancer Effects in Hepatocellular Carcinoma

open access: yesSmall Science, EarlyView.
Herein, a liver‐targeted nanohybrid formulation, SGLC/DOX@AG, is developed to enhance doxorubicin delivery and reduce vascular toxicity in hepatocellular carcinoma (HCC) treatment. Incorporating an albumin–glucosamine lipid complex, the system shows potent anticancer effects and minimized side effects across in vitro, in vivo, and cancer‐on‐a‐chip ...
Hyelim Kim   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy